BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34606125)

  • 21. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
    Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
    Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma.
    Wang Y; Tian X; Zhu SX; Xu WH; Anwaier A; Su JQ; Gan HL; Qu YY; Zhao JY; Zhang HL; Ye DW
    World J Surg Oncol; 2023 Mar; 21(1):98. PubMed ID: 36927438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
    Cao H; Zhang J; Wang W
    Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma.
    Tang Q; Pan D; Xu C; Chen L
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):231-245. PubMed ID: 36404389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of an immune-related prognostic model by exploring the tumor microenvironment of clear cell renal cell carcinoma.
    He J; Zhong Y; Sun Y; Xie C; Yu T
    Anal Biochem; 2022 Apr; 643():114567. PubMed ID: 35122734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of basement membrane-related prognostic signature for predicting prognosis, immune response and potential drug prediction in papillary renal cell carcinoma.
    Xi Y; Song L; Wang S; Zhou H; Ren J; Zhang R; Fu F; Yang Q; Duan G; Wang J
    Math Biosci Eng; 2023 Apr; 20(6):10694-10724. PubMed ID: 37322956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of immune-related biomarkers in adrenocortical carcinoma: Immune-related biomarkers for ACC.
    Peng Y; Song Y; Ding J; Li N; Zhang Z; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106930. PubMed ID: 32919215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma.
    Song Q; Zheng Y; Wu J; Wang S; Meng L; Yao Q; Li Z; Lian S
    Front Immunol; 2021; 12():717688. PubMed ID: 34630392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
    Lei S; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.
    Chen YH; Chen SH; Hou J; Ke ZB; Wu YP; Lin TT; Wei Y; Xue XY; Zheng QS; Huang JB; Xu N
    Aging (Albany NY); 2019 Oct; 11(21):9478-9491. PubMed ID: 31672930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
    Xia ZN; Wang XY; Cai LC; Jian WG; Zhang C
    FEBS Open Bio; 2021 Mar; 11(3):898-910. PubMed ID: 33449444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
    Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
    Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
    Ma Z; Xu J; Ru L; Zhu W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
    Chen Y; Meng Z; Zhang L; Liu F
    Front Immunol; 2021; 12():664845. PubMed ID: 33968066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
    Govindarajan A; Salgia NJ; Li H; Castro DV; Mirzapoiazova T; Armstrong B; Zhao D; Mercier BD; Dizman N; Chawla N; Zengin Z; Meza L; Tripathi N; Sayegh N; Chehrazi-Raffle A; Tripathi A; Pal SK
    Front Immunol; 2023; 14():1182581. PubMed ID: 37638025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.